In vivo evidence that erythropoietin has a neuroprotective effect during subarachnoid hemorrhage
- 30 March 2000
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 392 (1-2) , 31-34
- https://doi.org/10.1016/s0014-2999(00)00081-9
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Recombinant human erythropoietin inhibits iNOS activity and reverts vascular dysfunction in splanchnic artery occlusion shockBritish Journal of Pharmacology, 1999
- Erythropoietin Prevents Place Navigation Disability and Cortical Infarction in Rats with Permanent Occlusion of the Middle Cerebral ArteryBiochemical and Biophysical Research Communications, 1998
- Detection of erythropoietin in human liquor: Intrinsic erythropoietin production in the brainKidney International, 1997
- Brain Capillary Endothelial Cells Express two forms of Erythropoietin Receptor mRNAEuropean Journal of Biochemistry, 1996
- Erythropoietin Gene Expression in Human, Monkey and Murine BrainEuropean Journal of Neuroscience, 1996
- Behavioral Deficits Following Experimental Subarachnoid Hemorrhage in the RatJournal of Neurotrauma, 1994
- Effect of U88999E on Experimental Cerebral Vasospasm in RabbitsNeurosurgery, 1993
- Effects of Intravenous Administration of Recombinant Human Erythropoietin in Rats Subject to Hemorrhagic ShockNephron, 1993
- Does Erythropoietin Augment the Ca2+-Mediated K+ Flow into the Red Blood Cells in Normotensive and Hypertensive Subjects?Nephron, 1991
- Experimental cerebral vasospasm: Resolution by iloprostActa Neurochirurgica, 1988